2,000-plus business leaders surveyed show resounding optimism on economic prospects LONDON, July 14, 2025 /PRNewswire/ -- Moore Global, the global accounting,…
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of…
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd (“Avistone”), an innovative biotechnology company focused on precision oncology therapeutics, today announced that the…